You're the one making the case for DLE mate, not me, so surely you can find a 10 ktpa DLE DFS somewhere?
Even if we use your figure (US$500m), that's still A$770m that AGY would have to spend, and where does that come from? A partner means dilution (of shareholding or income and don't forget Pablo is still a minority partner), a cap raise means massive dilution, no-one's going to give AGY a loan that is ~5 x MC, and income from the 10 ktpa will already be foregone to a pre-paid offtake for years to fund the 10 ktpa expansion. And substantial synergies? The gym and the bakery don't cost that much mate.....
Honestly, this is pie in the sky stuff. I'd like to see AGY produce more that a couple of tonnes of lithium carbonate conventionally before we start dreaming about expansions into as yet unproven (at scale) technology with massive CAPEX requirements. Pablo's having a hard enough time getting a conventional operation to work.
- Forums
- ASX - By Stock
- AGY
- Ann: Rincon Lithium Project - Progress Update
AGY
argosy minerals limited
Add to My Watchlist
20.0%
!
1.8¢

Ann: Rincon Lithium Project - Progress Update, page-134
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.8¢ |
Change
0.003(20.0%) |
Mkt cap ! $26.20M |
Open | High | Low | Value | Volume |
1.6¢ | 2.3¢ | 1.6¢ | $899.2K | 44.43M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 1745031 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 1134176 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1045031 | 0.018 |
6 | 504117 | 0.017 |
10 | 1438810 | 0.016 |
15 | 2554023 | 0.015 |
33 | 4049845 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 1043916 | 5 |
0.021 | 880234 | 9 |
0.022 | 1464025 | 8 |
0.023 | 4200866 | 8 |
0.024 | 2694809 | 10 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online